Biotricity Inc. (BTCY) stock
BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.05+0.00 (+8.70%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Biotricity total assets
Total assets on the balance sheet at the end of each period.
Biotricity's total assets was $6.02M at Jun 30, 2026. For fiscal 2026 it was $6.45M, up 14.3% from the year before. The highest annual figure on record is $16.68M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $6.45M | +14.3% |
| FY2025 | Mar 31, 2025 | $5.64M | -5.1% |
| FY2024 | Mar 31, 2024 | $5.94M | -8.7% |
| FY2023 | Mar 31, 2023 | $6.51M | -61.0% |
| FY2022 | Mar 31, 2022 | $16.68M | +275.8% |
| FY2021 | Mar 31, 2021 | $4.44M | +121.4% |
| FY2020 | Mar 31, 2020 | $2.00M | +308.5% |
| FY2019 | Mar 31, 2019 | $490.66K | -47.2% |
| FY2018 | Mar 31, 2018 | $929.43K | – |
| FY2014 | Aug 31, 2014 | $0 | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $6.02M | -0.2% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $6.45M | +14.3% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $5.69M | -5.0% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $6.32M | +19.5% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $6.04M | +11.4% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $5.64M | -5.1% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $5.99M | +9.1% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $5.29M | -22.4% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $5.42M | -11.8% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $5.94M | -8.7% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $5.49M | -17.5% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $6.82M | -15.3% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $6.14M | -63.2% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $6.51M | -69.1% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $6.65M | -52.4% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $8.05M | +191.0% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $16.68M | +275.8% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $21.05M | +309.5% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $13.95M | +574.8% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $2.77M | +99.2% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $4.44M | +121.4% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $5.14M | -7.0% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $2.07M | +95.5% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $1.39M | +32.7% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $2.00M | +308.5% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $5.53M | +1068.8% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $1.06M | +152.2% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $1.05M | +12.6% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $490.66K | -80.9% |
| Q1 FY2019CQ2 2018 | Dec 31, 2018 | $473.10K | -29.1% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $419.42K | -66.2% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $929.43K | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $2.57M | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $667.41K | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $1.24M | – |
| Q4 FY2014CQ3 2014 | Aug 31, 2014 | $0 | – |
See a number that looks wrong?